Keeping Pace with the Untact Era... Samsung Biologics Opens Virtual Exhibition Hall

[Asia Economy Reporter Cho Hyun-ui] Samsung Biologics unveiled its virtual exhibition hall for the first time at "BIO Digital 2020," the world's largest pharmaceutical and bio event held digitally and remotely in the United States on the 8th (local time).

On the 9th, Samsung Biologics explained, "As this year's 'BIO International Convention' transitioned to a digital format, we attempted digital connections with customers through the virtual exhibition hall." Now in its 27th year, the BIO International Convention is usually held annually in major U.S. cities under the auspices of the Biotechnology Innovation Organization (BIO), but due to the COVID-19 pandemic, it was held digitally this time.

Samsung Biologics offers an innovative virtual experience for customers who want to learn more about the company and its services. The exhibition hall is broadly divided into three main business areas: CMO, CDO, and CRO, where visitors can vividly access detailed explanations of the company's services and facilities through various videos and graphic content.

A Samsung Biologics official said, "The exhibition hall is designed to give the feeling of actually seeing various parts of the company even without visiting in person," adding, "Through the virtual exhibition hall, we can actively respond to the rapidly changing business environment due to COVID-19 and lead innovation in the pharmaceutical and bio markets."

Visitors to the virtual exhibition hall can freely download desired information about Samsung Biologics from the resource library, and if they have additional questions, they can request further information or schedule one-on-one meetings with company representatives.

The virtual exhibition hall is optimized for both general computer and mobile environments, and since it utilizes global cloud infrastructure, it can be accessed from anywhere in the world without inconvenience regarding speed or accessibility.

Samsung Biologics plans to continue utilizing the virtual exhibition hall linked with the company's official website even after this event.

Kim Tae-han, CEO of Samsung Biologics, stated, "Through digital innovation, we will enable our customers to connect conveniently with our experts anytime and anywhere, beyond simple virtual meetings."

This content was produced with the assistance of AI translation services.